EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn 2B/− spinal muscular atrophy mice

Sharon J Brown, Darija Šoltić, Silvia A Synowsky, Sally L Shirran, Ellie Chilcott, Hannah K Shorrock, Thomas H Gillingwater iD, Rafael J Yáñez-Muñoz, Bernard Schneider, Melissa Bowerman iD, Heidi R Fuller iD

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddad121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Sharon J Brown und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Bioengineering, Keele University, Keele ST5 5BG, UK. Hauptthemen laut MEDLINE: Motor Neurons, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Great Ormond Street Hospital Charity, SPARKS Children’s Medical Research Charity, Muscular Dystrophy UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Structural, functional and molecular cardiac defects have been reported in spinal muscular atrophy (SMA) patients and mouse models. Previous quantitative proteomics analyses demonstrated widespread molecular defects in the severe Taiwanese SMA mouse model. Whether such changes are conserved across different mouse models, including less severe forms of the disease, has yet to be established. Here, using the same high-resolution proteomics approach in the less-severe Smn2B/− SMA mouse model, 277 proteins were found to be differentially abundant at a symptomatic timepoint (post-natal day (P) 18), 50 of which were similarly dysregulated in severe Taiwanese SMA mice. Bioinformatics analysis linked many of the differentially abundant proteins to cardiovascular development and function, with intermediate filaments highlighted as an enriched cellular compartment in both datasets. Lamin A/C was increased in the cardiac tissue, whereas another intermediate filament protein, desmin, was reduced. The extracellular matrix (ECM) protein, elastin, was also robustly decreased in the heart of Smn2B/− mice. AAV9-SMN1-mediated gene therapy rectified low levels of survival motor neuron protein and restored desmin levels in heart tissues of Smn2B/− mice. In contrast, AAV9-SMN1 therapy failed to correct lamin A/C or elastin levels. Intermediate filament proteins and the ECM have key roles in cardiac function and their dysregulation may explain cardiac impairment in SMA, especially since mutations in genes encoding these proteins cause other diseases with cardiac aberration. Cardiac pathology may need to be considered in the long-term care of SMA patients, as it is unclear whether currently available treatments can fully rescue peripheral pathology in SMA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Motor NeuronsMuscular Atrophy, SpinalHumansMiceAnimalsDesminElastinLamin Type AGenetic TherapyDisease Models, AnimalSurvival of Motor Neuron 1 Protein

Substanzen

DesminElastinLamin Type ASurvival of Motor Neuron 1 Protein

Autor:innen und Institutionen

  • School of Pharmacy and Bioengineering, Keele University, Keele ST5 5BG, UK.
  • Wolfson Centre for Inherited Neuromuscular Disease, TORCH Building, RJAH Orthopaedic Hospital, Oswestry SY10 7AG, UK.
  • BSRC Mass Spectrometry and Proteomics Facility, University of St Andrews, St Andrews KY16 9ST, UK.
  • AGCTlab.org, Centre of Gene and Cell Therapy, Centre for Biomedical Sciences, Department of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham Hill, Egham, Surre…
  • Edinburgh Medical School: Biomedical Sciences, Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh EH8 9XD, UK.
  • Bertarelli Platform for Gene Therapy, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1202 Geneva, Switzerland.

ORCID-Profile: Thomas H Gillingwater, Melissa Bowerman, Heidi R Fuller

Förderung

  • Great Ormond Street Hospital Charity
  • SPARKS Children’s Medical Research Charity
  • Muscular Dystrophy UK
  • Action Medical Research
  • Academy of Medical Sciences and Association Française contre les Myopathies
  • Euan MacDonald Centre for Motor Neuron Disease Research and SMA Europe
  • Royal Holloway University of London
  • UK SMA Research Consortium

Zitieren

APA

Brown, S. J., Šoltić, D., Synowsky, S. A., Shirran, S. L., Chilcott, E., Shorrock, H. K., Gillingwater, T. H., Yáñez-Muñoz, R. J., Schneider, B., Bowerman, M., & Fuller, H. R. (2023). AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn 2B/− spinal muscular atrophy mice. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad121

Vancouver

Brown SJ, Šoltić D, Synowsky SA, Shirran SL, Chilcott E, Shorrock HK, et al. AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn 2B/− spinal muscular atrophy mice. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad121

BibTeX
@article{Brown2023,
  author = {Brown, Sharon J and Šoltić, Darija and Synowsky, Silvia A and Shirran, Sally L and Chilcott, Ellie and Shorrock, Hannah K and Gillingwater, Thomas H and Yáñez-Muñoz, Rafael J and Schneider, Bernard and Bowerman, Melissa and Fuller, Heidi R},
  title = {AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn 2B/− spinal muscular atrophy mice},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddad121}
}
Kostenlos starten →